John D. Baxter

John D. Baxter

Nessuna posizione attualmente

83 anni
Health Technology
Electronic Technology
Commercial Services

Profilo

John D.
Baxter
founded California Biotechnology, Inc. in 1982 and served as its Director in 1992.
Dr. Baxter is also the founder of SciClone Pharmaceuticals LLC and Karo Healthcare AB.
Dr. Baxter held various former positions including Independent Director at Bionovo, Inc. from 2008 to 2012, Director at RxSight, Inc., National Academy of Sciences, National Academy of Medicine (United States), and One Touch Technologies, Inc. Dr. Baxter was also a Professor at The University of California, San Francisco from 1970 to 2008 and served as President of The Endocrine Society in 2002-2003.
Dr. Baxter was Co-Director-Diabetes Research Center at The Methodist Hospital Research Institute from 2010 to 2012 and Head-Endocrinology at Methodist Hospital of Houston in 2011-2012.

Precedenti posizioni note di John D. Baxter

SocietàPosizioneFine
BIONOVO INC. Direttore/Membro del Consiglio 04/01/2012
Direttore/Membro del Consiglio 04/01/2012
Direttore/Membro del Consiglio 04/01/2012
The Methodist Hospital Research Institute Corporate Officer/Principal 04/01/2012
Direttore/Membro del Consiglio 04/01/2012
Vedi nel dettaglio l'esperienza di John D. Baxter

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John D. Baxter

Relazioni

100 +

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
RXSIGHT, INC.

Electronic Technology

KARO PHARMA AB (PUBL)

Health Technology

Aziende private9

Health Technology

Health Technology

California Biotechnology, Inc.

Health Technology

Commercial Services

Commercial Services

Health Services

The Endocrine Society

The Methodist Hospital Research Institute

Electronic Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. John D. Baxter
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA